Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon beta therapy for multiple sclerosis

D E Goodkin1

  • 1MS Center, Department of Neurology, University of California San Francisco, 94115, USA.

Lancet (London, England)
|November 20, 1998
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy.

Journal of neurology, neurosurgery, and psychiatry·2003
Same author

T2 relaxation time histograms in multiple sclerosis.

Magnetic resonance imaging·2003
Same author

3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.

Magnetic resonance imaging·2002
Same author

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

Neurology·2002
Same author

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.

Neurology·2002
Same author

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.

Journal of consulting and clinical psychology·2002